ENvue Medical, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−96.17 USD
−3.71 M USD
2.56 M USD
1.08 M
About ENvue Medical, Inc.
Sector
Industry
CEO
Doron Robert Besser
Website
Headquarters
Tyler
Founded
2003
Identifiers
3
ISIN US63008J8844
ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FEED is 2.30 USD — it has increased by 119.05% in the past 24 hours. Watch ENvue Medical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ENvue Medical, Inc. stocks are traded under the ticker FEED.
FEED stock has risen by 85.48% compared to the previous week, the month change is a −7.26% fall, over the last year ENvue Medical, Inc. has showed a −99.95% decrease.
FEED reached its all-time high on Aug 31, 2016 with the price of 41,140,000.00 USD, and its all-time low was 1.10 USD and was reached on Jan 16, 2026. View more price dynamics on FEED chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FEED stock is 135.14% volatile and has beta coefficient of 4.09. Track ENvue Medical, Inc. stock price on the chart and check out the list of the most volatile stocks — is ENvue Medical, Inc. there?
Today ENvue Medical, Inc. has the market capitalization of 1.14 M, it has decreased by −10.57% over the last week.
Yes, you can track ENvue Medical, Inc. financials in yearly and quarterly reports right on TradingView.
ENvue Medical, Inc. is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
FEED net income for the last quarter is 600.00 K USD, while the quarter before that showed −156.00 K USD of net income which accounts for 484.62% change. Track more ENvue Medical, Inc. financial stats to get the full picture.
No, FEED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 29, 2026, the company has 31 employees. See our rating of the largest employees — is ENvue Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENvue Medical, Inc. EBITDA is −8.81 M USD, and current EBITDA margin is −139.99%. See more stats in ENvue Medical, Inc. financial statements.
Like other stocks, FEED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENvue Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENvue Medical, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENvue Medical, Inc. stock shows the sell signal. See more of ENvue Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.